These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11684507)

  • 1. Drugs or psychotherapy for the elderly?
    Harv Ment Health Lett; 2001 Oct; 18(4):7. PubMed ID: 11684507
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.
    Dombrovski AY; Lenze EJ; Dew MA; Mulsant BH; Pollock BG; Houck PR; Reynolds CF
    J Am Geriatr Soc; 2007 Sep; 55(9):1325-32. PubMed ID: 17767673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of paroxetine in fatigue and depression of patients under chemotherapeutic treatment.
    Heras P; Kritikos K; Hatzopoulos A; Kritikos N; Heras V; Mitsibounas D
    Am J Ther; 2013; 20(3):254-6. PubMed ID: 19262364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of non-psychotic depression in outpatient clinic].
    Ivanets NN; Kinkul'kina MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):60-2. PubMed ID: 16768229
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychotherapy and paroxetine: cost effective for severe IBS, or a waste of resources.
    Chitkara DK; Cremonini F; Talley NJ
    Gastroenterology; 2003 Nov; 125(5):1554-5; author reply 1555-6. PubMed ID: 14628812
    [No Abstract]   [Full Text] [Related]  

  • 6. [Patient safety with breast cancer and depression: Concomitant use of paroxetine and tamoxifen].
    Muquebil Ali Al Shaban Rodríguez OW; Pérez Castro P; Estrada Alarcón N; Tuñón Gorgojo L
    J Healthc Qual Res; 2019; 34(2):110-111. PubMed ID: 30686622
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
    Hwang JP; Yang CH; Tsai SJ
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):189-90. PubMed ID: 14758586
    [No Abstract]   [Full Text] [Related]  

  • 8. Do new-generation antidepressants work?
    Kelly BD
    Ir Med J; 2008 May; 101(5):155. PubMed ID: 18624267
    [No Abstract]   [Full Text] [Related]  

  • 9. [Application of antidepressant to treat patients in the department of otolaryngology].
    Goto F; Tsutsumi T; Ogawa K
    Nihon Rinsho; 2012 Jan; 70(1):115-21. PubMed ID: 22413504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
    Reznik AM; Arbuzov AL; Khurbatova IG
    Voen Med Zh; 2007 Jan; 328(1):38-43. PubMed ID: 17436713
    [No Abstract]   [Full Text] [Related]  

  • 12. [Narcoleptic syndrome as a possible side effect of paroxetine].
    Alonso H; Ortí-Pareja M; Jiménez-Jiménez FJ
    Rev Neurol; 2004 Dec 1-15; 39(11):1092. PubMed ID: 15597274
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopaminergic sensitivity and prediction of antidepressant response.
    Watson S; Young A
    J Psychopharmacol; 2000; 14(4):419. PubMed ID: 11198062
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.
    Creed F; Fernandes L; Guthrie E; Palmer S; Ratcliffe J; Read N; Rigby C; Thompson D; Tomenson B;
    Gastroenterology; 2003 Feb; 124(2):303-17. PubMed ID: 12557136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine: a review of clinical experience.
    Dunner D; Kumar R
    Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsychosocial treatment of irritable bowel syndrome.
    Dill JE; Dill BP
    Gastroenterology; 2003 Nov; 125(5):1554; author reply 1555-6. PubMed ID: 14628811
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of paroxetine for the treatment of depression in the context of HIV infection.
    Grassi B; Gambini O; Garghentini G; Lazzarin A; Scarone S
    Pharmacopsychiatry; 1997 Mar; 30(2):70-1. PubMed ID: 9131727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depression.
    Hayashi H; Akahane T; Suzuki H; Sasaki T; Kawakatsu S; Otani K
    Clin Neuropharmacol; 2010; 33(1):48-9. PubMed ID: 19935408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal convulsions secondary to paroxetine withdrawal.
    Ahmed M; Parameshwaran A; Swamy P
    J Pak Med Assoc; 2007 Mar; 57(3):162. PubMed ID: 17432029
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
    Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I
    J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.